Medical data research company Truveta said on Monday that Regeneron Pharmaceuticals REGN.O, Illumina ILMN.O and 17 U.S. health systems will take a $320 million stake in the company as part of a deal to build the world’s largest genetic database. The deal values privately held Truveta at more than $1 billion, it said. Biotechnology company …

The post Truveta sells stakes in key deal to build the world’s largest genetic database appeared first on AL24 News.